• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于深度学习的病理学图像分析增强了马吉特征与Oncotype DX乳腺癌复发评分的相关性。

Deep Learning-Based Pathology Image Analysis Enhances Magee Feature Correlation With Oncotype DX Breast Recurrence Score.

作者信息

Li Hongxiao, Wang Jigang, Li Zaibo, Dababneh Melad, Wang Fusheng, Zhao Peng, Smith Geoffrey H, Teodoro George, Li Meijie, Kong Jun, Li Xiaoxian

机构信息

Department of Mathematics and Statistics, Georgia State University, Atlanta, GA, United States.

Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

出版信息

Front Med (Lausanne). 2022 Jun 14;9:886763. doi: 10.3389/fmed.2022.886763. eCollection 2022.

DOI:10.3389/fmed.2022.886763
PMID:35775006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9239530/
Abstract

BACKGROUND

Oncotype DX Recurrence Score (RS) has been widely used to predict chemotherapy benefits in patients with estrogen receptor-positive breast cancer. Studies showed that the features used in Magee equations correlate with RS. We aimed to examine whether deep learning (DL)-based histology image analyses can enhance such correlations.

METHODS

We retrieved 382 cases with RS diagnosed between 2011 and 2015 from the Emory University and the Ohio State University. All patients received surgery. DL models were developed to detect nuclei of tumor cells and tumor-infiltrating lymphocytes (TILs) and segment tumor cell nuclei in hematoxylin and eosin (H&E) stained histopathology whole slide images (WSIs). Based on the DL-based analysis, we derived image features from WSIs, such as tumor cell number, TIL number variance, and nuclear grades. The entire patient cohorts were divided into one training set (125 cases) and two validation sets (82 and 175 cases) based on the data sources and WSI resolutions. The training set was used to train the linear regression models to predict RS. For prediction performance comparison, we used independent variables from Magee features alone or the combination of WSI-derived image and Magee features.

RESULTS

The Pearson's correlation coefficients between the actual RS and predicted RS by DL-based analysis were 0.7058 (-value = 1.32 × 10) and 0.5041 (-value = 1.15 × 10) for the validation sets 1 and 2, respectively. The adjusted values using Magee features alone are 0.3442 and 0.2167 in the two validation sets, respectively. In contrast, the adjusted values were enhanced to 0.4431 and 0.2182 when WSI-derived imaging features were jointly used with Magee features.

CONCLUSION

Our results suggest that DL-based digital pathological features can enhance Magee feature correlation with RS.

摘要

背景

Oncotype DX复发评分(RS)已被广泛用于预测雌激素受体阳性乳腺癌患者的化疗获益。研究表明,Magee方程中使用的特征与RS相关。我们旨在研究基于深度学习(DL)的组织学图像分析是否能增强这种相关性。

方法

我们从埃默里大学和俄亥俄州立大学检索了2011年至2015年间诊断出RS的382例病例。所有患者均接受了手术。开发DL模型以检测苏木精和伊红(H&E)染色的组织病理学全切片图像(WSIs)中的肿瘤细胞核和肿瘤浸润淋巴细胞(TILs),并分割肿瘤细胞核。基于DL分析,我们从WSIs中提取图像特征,如肿瘤细胞数量、TIL数量方差和核分级。根据数据源和WSI分辨率,将整个患者队列分为一个训练集(125例)和两个验证集(82例和175例)。训练集用于训练线性回归模型以预测RS。为了比较预测性能,我们单独使用Magee特征的自变量或WSI衍生图像和Magee特征的组合。

结果

验证集1和验证集2中,基于DL分析的实际RS与预测RS之间的Pearson相关系数分别为0.7058(P值 = 1.32×10)和0.5041(P值 = 1.15×10)。在两个验证集中,单独使用Magee特征的调整后R²值分别为0.3442和0.2167。相比之下,当WSI衍生的成像特征与Magee特征联合使用时,调整后R²值分别提高到0.4431和0.2182。

结论

我们的结果表明,基于DL的数字病理特征可以增强Magee特征与RS的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/030d29adc52c/fmed-09-886763-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/b12e7c91a7a2/fmed-09-886763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/ff4f287a3da7/fmed-09-886763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/7aff7f1f09b8/fmed-09-886763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/e8da144eb56b/fmed-09-886763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/c7a70ae77bf4/fmed-09-886763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/030d29adc52c/fmed-09-886763-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/b12e7c91a7a2/fmed-09-886763-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/ff4f287a3da7/fmed-09-886763-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/7aff7f1f09b8/fmed-09-886763-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/e8da144eb56b/fmed-09-886763-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/c7a70ae77bf4/fmed-09-886763-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ce/9239530/030d29adc52c/fmed-09-886763-g006.jpg

相似文献

1
Deep Learning-Based Pathology Image Analysis Enhances Magee Feature Correlation With Oncotype DX Breast Recurrence Score.基于深度学习的病理学图像分析增强了马吉特征与Oncotype DX乳腺癌复发评分的相关性。
Front Med (Lausanne). 2022 Jun 14;9:886763. doi: 10.3389/fmed.2022.886763. eCollection 2022.
2
Breast cancer tumor heterogeneity has only little impact on the estimation of the Oncotype DX® recurrence score using Magee Equations and Magee Decision Algorithm™.乳腺癌肿瘤异质性对使用 Magee 方程和 Magee 决策算法™ 估算 Oncotype DX® 复发评分的影响很小。
Hum Pathol. 2021 Feb;108:51-59. doi: 10.1016/j.humpath.2020.11.006. Epub 2020 Nov 24.
3
Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay).使用改良的马吉方程来识别不太可能从21基因复发评分检测(Oncotype DX检测)中获益的患者。
Am J Clin Pathol. 2017 Jun 1;147(6):541-548. doi: 10.1093/ajcp/aqx008.
4
Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.使用改良的 Magee 方程和组织学标准预测 Oncotype DX 复发评分。
Mod Pathol. 2015 Jul;28(7):921-31. doi: 10.1038/modpathol.2015.50. Epub 2015 May 1.
5
Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.预测 Oncotype DX 复发评分:使用通过线性回归分析得出的病理生成方程。
Mod Pathol. 2013 May;26(5):658-64. doi: 10.1038/modpathol.2013.36. Epub 2013 Mar 15.
6
Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast.Oncotype DX与改良马吉方程复发评分在乳腺低级别浸润性癌中的比较
Am J Clin Pathol. 2017 Aug 1;148(2):167-172. doi: 10.1093/ajcp/aqx059.
7
Correlation between modified Magee equation-2 and Oncotype-Dx recurrence scores using both traditional and TAILORx cutoffs and the clinical application of the Magee Decision Algorithm: a single institutional review.使用传统和TAILORx临界值的改良Magee方程-2与Oncotype-Dx复发评分之间的相关性以及Magee决策算法的临床应用:一项单机构回顾
Breast Cancer. 2021 Mar;28(2):321-328. doi: 10.1007/s12282-020-01163-3. Epub 2020 Sep 20.
8
Applying new Magee equations for predicting the Oncotype Dx recurrence score.应用新的 Magee 方程预测 Oncotype Dx 复发评分。
Breast Cancer. 2018 Sep;25(5):597-604. doi: 10.1007/s12282-018-0860-x. Epub 2018 Apr 24.
9
Comparison of Magee and Oncotype DX Recurrence Scores in estrogen receptor positive breast cancers.比较 Magee 和 Oncotype DX 复发评分在雌激素受体阳性乳腺癌中的应用。
Breast J. 2018 Nov;24(6):951-956. doi: 10.1111/tbj.13108. Epub 2018 Sep 19.
10
The Correlation of Magee Equations and Oncotype DX Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer.在预测雌激素受体阳性(ER+)和人表皮生长因子受体2阴性(HER2-)乳腺癌新辅助化疗反应中,麦吉方程与来自粗针活检组织的Oncotype DX复发评分的相关性
Eur J Breast Health. 2020 Apr 1;16(2):117-123. doi: 10.5152/ejbh.2020.5338. eCollection 2020 Apr.

引用本文的文献

1
A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death.三阴性乳腺癌的一种20特征放射组学特征可识别出死亡风险高的患者。
NPJ Breast Cancer. 2025 Jul 26;11(1):79. doi: 10.1038/s41523-025-00790-3.
2
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy Benefit.基于组织病理学图像的深度学习预测乳腺癌复发风险及化疗获益
medRxiv. 2025 May 16:2025.05.15.25327686. doi: 10.1101/2025.05.15.25327686.
3
Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides.

本文引用的文献

1
Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues.自然杀伤细胞除肿瘤浸润淋巴细胞外对乳腺癌组织的预后价值。
Clin Breast Cancer. 2021 Dec;21(6):e738-e747. doi: 10.1016/j.clbc.2021.02.003. Epub 2021 Feb 16.
2
Different Breast Cancer Subtypes Show Different Metastatic Patterns: A Study from A Large Public Database.不同乳腺癌亚型表现出不同的转移模式:来自大型公共数据库的研究。
Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3587-3593. doi: 10.31557/APJCP.2020.21.12.3587.
3
An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
基于数字化乳腺癌组织切片的深度学习转移性复发风险评估
Nat Commun. 2025 Jul 1;16(1):5876. doi: 10.1038/s41467-025-60824-z.
4
Multimodal recurrence risk prediction model for HR+/HER2- early breast cancer following adjuvant chemo-endocrine therapy: integrating pathology image and clinicalpathological features.辅助化疗-内分泌治疗后HR+/HER2-早期乳腺癌的多模态复发风险预测模型:整合病理图像和临床病理特征
Breast Cancer Res. 2025 Mar 28;27(1):27. doi: 10.1186/s13058-025-01968-0.
5
Multimodal histopathologic models stratify hormone receptor-positive early breast cancer.多模态组织病理学模型对激素受体阳性早期乳腺癌进行分层。
Nat Commun. 2025 Mar 2;16(1):2106. doi: 10.1038/s41467-025-57283-x.
6
Development and validation of a clinical breast cancer tool for accurate prediction of recurrence.一种用于准确预测复发的临床乳腺癌工具的开发与验证。
NPJ Breast Cancer. 2024 Jun 15;10(1):46. doi: 10.1038/s41523-024-00651-5.
7
Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer-The BRAIN Study.在雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌中使用机器学习预测多基因检测(Oncotype DX和Mammaprint)复发风险组——BRAIN研究
Cancers (Basel). 2024 Feb 13;16(4):774. doi: 10.3390/cancers16040774.
8
AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer.基于人工智能的常规苏木精-伊红(H&E)图像的早期腔面型乳腺癌预后标志物
NPJ Precis Oncol. 2023 Nov 15;7(1):122. doi: 10.1038/s41698-023-00472-y.
9
Radiogenomics: a key component of precision cancer medicine.放射组学:精准肿瘤医学的关键组成部分。
Br J Cancer. 2023 Sep;129(5):741-753. doi: 10.1038/s41416-023-02317-8. Epub 2023 Jul 6.
10
Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence.整合临床特征与病理学深度学习以预测乳腺癌复发检测及复发风险
NPJ Breast Cancer. 2023 Apr 14;9(1):25. doi: 10.1038/s41523-023-00530-5.
一种用于经皮穿刺活检全切片图像中前列腺癌诊断的人工智能算法:一项盲法临床验证与应用研究。
Lancet Digit Health. 2020 Aug;2(8):e407-e416. doi: 10.1016/S2589-7500(20)30159-X.
4
A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations.化生性乳腺癌的全面概述:临床特征和分子异常。
Breast Cancer Res. 2020 Nov 4;22(1):121. doi: 10.1186/s13058-020-01353-z.
5
Molecular Drivers of Onco DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.Onco DX、Prosigna、EndoPredict 和 Breast Cancer Index 的分子驱动因素:TransATAC 研究。
J Clin Oncol. 2021 Jan 10;39(2):126-135. doi: 10.1200/JCO.20.00853. Epub 2020 Oct 27.
6
HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer.人表皮生长因子受体2(HER2)免疫组化染色阳性强烈预示着HER2阳性乳腺癌患者对新辅助化疗的肿瘤反应。
Pathol Res Pract. 2020 Nov;216(11):153155. doi: 10.1016/j.prp.2020.153155. Epub 2020 Aug 10.
7
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies.评估曲妥珠单抗联合紫杉类药物新辅助治疗后 HER2 阳性乳腺癌中 PD-L1、肿瘤浸润淋巴细胞及 CD8+、FOXP3+免疫细胞的表达。
Breast Cancer Res Treat. 2020 Oct;183(3):599-606. doi: 10.1007/s10549-020-05819-8. Epub 2020 Jul 26.
8
Deep-learning-based accurate hepatic steatosis quantification for histological assessment of liver biopsies.基于深度学习的肝脂肪变性定量分析用于肝活检的组织学评估。
Lab Invest. 2020 Oct;100(10):1367-1383. doi: 10.1038/s41374-020-0463-y. Epub 2020 Jul 13.
9
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study.Magee 方程与 ER+/HER2- 阴性乳腺癌新辅助化疗的反应:一项多机构研究。
Mod Pathol. 2021 Jan;34(1):77-84. doi: 10.1038/s41379-020-0620-2. Epub 2020 Jul 13.
10
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.TILs 与早期 HER2 阴性乳腺癌(BC)患者临床参数、Recurrence Score® 结果和预后的关系——前瞻性 WSG PlanB 试验的转化分析。
Breast Cancer Res. 2020 May 14;22(1):47. doi: 10.1186/s13058-020-01283-w.